Countries North America
Kexing Biopharm’s GB18 Receives IND Approval in China and U.S. for Cancer Cachexia Treatment
Kexing Biopharm (688136.SH) announced that the National Medical Products Administration (NMPA) has approved the Investigational New Drug (IND) applica...
May 30, 2025 | News
Teddy Laboratory and LabConnect Forge Global Lab Alliance to Accelerate Drug Development
Teddy Laboratory, a subsidiary of Tigermed, officially signed a strategic cooperation agreement with LabConnect, LLC, a global leader in central labor...
May 30, 2025 | News
Celltrion’s YUFLYMA® Wins Expanded Interchangeability Status for All Humira® Dosage Forms in the U.S.
YUFLYMA® (adalimumab-aaty) is a high-concentration (100mg/mL) and citrate-free formulation of Humira® (adalimumab) biosimilar[1] Cellt...
May 26, 2025 | News
Pfizer Strikes $1.25B Ex-China Licensing Deal With China’s 3SBio for Cancer Antibody SSGJ-707
Pfizer Inc. announced it has entered into an exclusive global, ex-China, licensing agreement with 3SBio, Inc. (01530.HK), a leading Chinese biopharmaceutic...
May 20, 2025 | News
Lunit Expands U.S. Footprint with AI-Powered Breast Cancer Screening at Over 200 Sites
Building on Volpara's breast health expertise, Lunit strengthens its U.S. presence—now delivering AI-powered breast cancer screening across 200 imagi...
May 20, 2025 | News
BoomerangFX Launches LeadEngineAI™ Featuring AUVIA™ Across North America, Europe, and Asia-Pacific to Transform Patient Acquisition in Private Healthcare Clinics
BoomerangFX, the leading AI-powered SaaS platform for private-pay healthcare clinics, announced the global launch of LeadEngineAI™, a transform...
May 19, 2025 | News
AGC Biologics Partners with Quell Therapeutics to Advance Treg Cell Therapies for Immune Disorders
-AGC Biologics, your friendly CDMO expert, announced a partnership with Quell Therapeutics (“Quell”), a clinical-stage bio...
May 19, 2025 | News
Alamar Biosciences Expands NULISAseq™ CNS Disease Panel 120 to Include Brain-Derived pTau Assays for Alzheimer’s and Tauopathy Research
Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, today announced the expansion of its NULISAse...
May 16, 2025 | News
GSK Acquires Efimosfermin from Boston Pharmaceuticals in $2 Billion Deal to Advance Liver Disease Pipeline
Affecting up to 5% of the global population, SLD represents an area of significant unmet medical need with limited treatment options Phase II data show ...
May 15, 2025 | News
Eli Lilly Commits $250M to Purdue University in Landmark U.S. Industry-Academic Alliance
Eli Lilly and Company (NYSE: LLY) and Purdue University announced a significant expansion of their long-standing alliance, with Lilly'...
May 13, 2025 | News
Roche and Genentech Invest $700M in First U.S. East Coast Facility to Advance Obesity Drug Manufacturing
Future 700,000 sq. ft. facility in Holly Springs, NC, will support pharma division’s metabolic medicines portfolio $700+ million investm...
May 13, 2025 | News
Colorcon Enters Exclusive Partnership with ASHA Cellulose to Expand Ethyl Cellulose Offerings Across Asia, EMEA
Colorcon, a global leader of film coating systems, specialty excipients, controlled release formulations and controlled atmosphere packaging for the health...
May 09, 2025 | News
Altaris Unites WuXi and Minaris Assets to Launch Minaris Advanced Therapies as Global Cell Therapy CDMO Powerhouse
Through strategic acquisitions made by New York–based investment firm Altaris, Minaris Regenerative Medicine and the U.S. and U.K. operations of WuXi...
May 08, 2025 | News
AstraZeneca and Daiichi Sankyo’s ENHERTU Demonstrates Superior pCR in Early HER2+ Breast Cancer in Phase 3 DESTINY-Breast11 Trial
Positive topline results from the DESTINY-Breast11 phase 3 trial showed ENHERTU® (trastuzumab deruxtecan) followed by paclitaxel, trastu...
May 08, 2025 | News
Most Read
- Bridging the Vision Gap: Roche’s Ahmed Elhusseiny on Eye Health Priorities in Asia Pacific
- How Merck’s India-Based Navi Mumbai Centre is Reimagining Formulation Science for the Global Generics Market
- Advancing Cell & Gene Therapy in APJ: How Thermo Fisher Enables Breakthrough Innovation
- AstraZeneca’s Vision for Chronic Kidney Disease: Sylvia Varela on Transforming CKD Care in Asia
- ACG Leads the Charge in Vegan Capsules: Innovation, Certification, and the Future of Sustainable Pharma
- ORA’s Hybrid Model Reshapes Obesity Care: Dr. Ben Ng on Bridging Telehealth and In-Person Treatment
- Heather Hargett on How Merck’s HUB Organoids Acquisition is Reshaping 3D Cell Culture and Drug Development
- Health2Sync's Vision for Diabetes Care: Transforming Outcomes Through Technology and Partnerships
Bio Jobs
- Ravindra Rao Joins GOBI Technologies as Director of Life Sciences – APAC
- Amgen Announces $900 Million Expansion of Ohio Biomanufacturing Facility, Boosting Investment to Over $1.4 Billion
- Thermo Fisher Scientific Appoints Former CVS Health CEO Karen S. Lynch to Board of Directors
- Merck KGaA Reshapes Leadership for the Future with Key Executive Moves
- Aarian Health Appoints Thomas Keller as Business Director to Drive Innovation and Growth
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
News
Editor Picks
